Mechanisms and consequences of methylating agent-induced SCEs and chromosomal aberrations: a long road traveled and still a far way to go

Since the milestone work of Evans and Scott, demonstrating the replication dependence of alkylation-induced aberrations, and Obe and Natarajan, pointing to the critical role of DNA double-strand breaks (DSBs) as the ultimate trigger of aberrations, the field has grown extensively. A notable example is the identification of DNA methylation lesions provoking chromosome breakage (clastogenic) effects, which made it possible to model clastogenic pathways evoked by genotoxins. Experiments with repair-deficient mutants and transgenic cell lines revealed both O6-methylguanine (O6MeG) and N- methylpurines as critical lesions. For SN2 agents such as methyl- methanesulfonate (MMS), base N-methylation lesions are most critical, likely because of the formation of apurinic sites blocking replication. For SN1 agents, such as N-methyl-N′-nitro-N-nitrosoguanidine (MNNG), O6-methylguanine (O6MeG) plays the major role both in recombination and clastogenicity in the post-treatment cell cycle, provided the lesion is not pre-replicatively repaired by O6-methylguanine-DNA methyltransferase (MGMT). The conversion probability of O6MeG into SCEs and chromosomal aberrations is estimated to be about 30:1 and >10,000:1 respectively, indicating this mispairing pro-mutagenic lesion to be highly potent in inducing recombination giving rise to SCEs. O6MeG needs replication and mismatch repair to become converted into a critical secondary genotoxic lesion. Here it is proposed that this secondary lesion can be tolerated by a process termed recombination bypass. This process is supposed to be important in the tolerance of lesions that can not be processed by translesion synthesis accomplished by low-fidelity DNA polymerases. Recombination bypass results in SCEs and might represent an alternative pathway of tolerance of non-instructive lesions. In the case of O6MeG-derived secondary lesions, recombination bypass appears to protect against cell killing since SCEs are already induced with low, non-toxic doses of MNNG. Saturation of lesion tolerance by recombination bypass or translesion synthesis may cause block of DNA replication leading to DSBs at stalled replication forks, which result in chromatid-type aberrations. Along with this model, several putative consequences of methylation-induced aberrations will be discussed such as cell death by apoptosis as well its role in tumor promotion and progression.

[1]  T. Ohmoto,et al.  Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease. , 1994, Mutation research.

[2]  S. K. Greenwood,et al.  Fewer chromosome aberrations and earlier apoptosis induced by DNA synthesis inhibitors, a topoisomerase II inhibitor or alkylating agents in human cells with normal compared with mutant p53. , 1998, Mutation research.

[3]  R. Warzok,et al.  Nitrosated urea pesticide metabolites and other nitrosamides. Activity in clastogenicity and SCE assays, and aberration kinetics in Chinese hamster V79-E cells. , 1980, Mutation research.

[4]  B. Kaina,et al.  Effect of ultraviolet light, methyl methanesulfonate and ionizing radiation on the genotoxic response and apoptosis of mouse fibroblasts lacking c-Fos, p53 or both. , 2001, Mutagenesis.

[5]  A. Natarajan,et al.  Relationship between cell killing, chromosomal aberrations, sister-chromatid exchanges and point mutations induced by monofunctional alkylating agents in Chinese hamster cells. A correlation with different ethylation products in DNA. , 1984, Mutation research.

[6]  M. Christmann,et al.  Nuclear Translocation of Mismatch Repair Proteins MSH2 and MSH6 as a Response of Cells to Alkylating Agents* , 2000, The Journal of Biological Chemistry.

[7]  M. Christmann,et al.  Mechanisms of human DNA repair: an update. , 2003, Toxicology.

[8]  S. Haas,et al.  Transgenic systems in studies on genotoxicity of alkylating agents: critical lesions, thresholds and defense mechanisms. , 1998, Mutation research.

[9]  L. Samson,et al.  O6-alkylguanine DNA lesions trigger apoptosis. , 1998, Carcinogenesis.

[10]  T. Noda,et al.  Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Clarke,et al.  Induction of murine O6-alkylguanine-DNA-alkyltransferase in response to ionising radiation is p53 gene dose dependent. , 1996, Oncogene.

[12]  R. Saffhill,et al.  DNA synthesis with methylated poly(dC-dG) templates. Evidence for a competitive nature to miscoding by O(6)-methylguanine. , 1979, Biochimica et biophysica acta.

[13]  A. Lehmann.  Replication of damaged DNA in mammalian cells: new solutions to an old problem. , 2002, Mutation research.

[14]  M. Tomicic,et al.  Comparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, ganciclovir and penciclovir. , 2002, Mutation research.

[15]  G. Obe,et al.  Insights into the mechanisms of sister chromatid exchange formation , 2004, Cytogenetic and Genome Research.

[16]  R. Mirzayans,et al.  On the quantitative relationship between O6-methylguanine residues in genomic DNA and production of sister-chromatid exchanges, mutations and lethal events in a Mer- human tumor cell line. , 1994, Mutation research.

[17]  B. Kaina,et al.  Chromosomal aberrations as a contributing factor for tumor promotion in the mouse skin. , 1989, Teratogenesis, carcinogenesis, and mutagenesis.

[18]  B. Kaina,et al.  Dependency of the yield of sister-chromatid exchanges induced by alkylating agents on fixation time. Possible involvement of secondary lesions in sister-chromatid exchange induction. , 1985, Mutation research.

[19]  D. Bootsma,et al.  Induction of sister chromatid exchanges in xeroderma pigmentosum cells after exposure to ultraviolet light. , 1977, Mutation research.

[20]  R. Painter,et al.  The Hela DNA-synthesis inhibition test as a rapid screen for mutagenic carcinogens. , 1982, Mutation research.

[21]  P. Hanawalt,et al.  p53-Mediated DNA Repair Responses to UV Radiation: Studies of Mouse Cells Lacking p53, p21, and/orgadd45 Genes , 2000, Molecular and Cellular Biology.

[22]  A. Natarajan,et al.  Molecular mechanisms involved in the production of chromosomal aberrations. I. Utilization of Neurospora endonuclease for the study of aberration production in G2 stage of the cell cycle. , 1978, Mutation research.

[23]  B. Kaina,et al.  Chromosomal instability, reproductive cell death and apoptosis induced by O6-methylguanine in Mex-, Mex+ and methylation-tolerant mismatch repair compromised cells: facts and models. , 1997, Mutation research.

[24]  B. Kaina,et al.  Overexpression of N-methylpurine-DNA glycosylase in Chinese hamster ovary cells renders them more sensitive to the production of chromosomal aberrations by methylating agents--a case of imbalanced DNA repair. , 1995, Mutation research.

[25]  B. Kaina,et al.  The action of N-methyl-N-nitrosourea on non-established human cell lines in vitro. I. Cell cycle inhibition and aberration induction in diploid and Down's fibroblasts. , 1977, Mutation research.

[26]  B. Kaina,et al.  DNA repair protein MGMT protects against N-methyl-N-nitrosourea-induced conversion of benign into malignant tumors. , 2003, Carcinogenesis.

[27]  M. Armstrong,et al.  Mismatch repair provokes chromosome aberrations in hamster cells treated with methylating agents or 6-thioguanine, but not with ethylating agents. , 1997, Mutation research.

[28]  B. Kaina,et al.  Apoptosis induced by MNNG in human TK6 lymphoblastoid cells is p53 and Fas/CD95/Apo-1 related. , 2003, Mutation research.

[29]  T. Tsuzuki,et al.  Alkylation-induced apoptosis of embryonic stem cells in which the gene for DNA-repair, methyltransferase, had been disrupted by gene targeting. , 1997, Carcinogenesis.

[30]  Samuel H. Wilson,et al.  A role for p53 in base excision repair , 2001, The EMBO journal.

[31]  A E Pegg,et al.  Methylation of the O6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents. , 1984, Cancer investigation.

[32]  M. Paterson,et al.  Initiation of strand incision at G:T and O(6)-methylguanine:T base mismatches in DNA by human cell extracts. , 2001, Nucleic acids research.

[33]  B. Kaina.  Critical steps in alkylation-induced aberration formation. , 1998, Mutation research.

[34]  B. Kaina,et al.  Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents. , 1991, Carcinogenesis.

[35]  A. Natarajan,et al.  The relation between reaction kinetics and mutagenic action of mono-functional alkylating agents in higher eukaryotic systems. I. Recessive lethal mutations and translocations in Drosophila. , 1979, Mutation research.

[36]  S. K. Greenwood,et al.  A role for mismatch repair in production of chromosome aberrations by methylating agents in human cells. , 1995, Mutation research.

[37]  B. Kaina,et al.  Contribution of O6‐alkylguanine and N‐alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: New insights gained from studies of genetically engineered mammalian cell lines , 1993, Environmental and molecular mutagenesis.

[38]  D. Lilley,et al.  Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Kaina,et al.  Loss of ATM sensitizes against O6-methylguanine triggered apoptosis, SCEs and chromosomal aberrations. , 2004, DNA repair.

[40]  D. Scott,et al.  The induction of chromosome aberrations by nitrogen mustard and its dependence on DNA synthesis , 1969, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[41]  T. Ishikawa,et al.  O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Kaina,et al.  Primary mouse fibroblasts deficient for c-Fos, p53 or for both proteins are hypersensitive to UV light and alkylating agent-induced chromosomal breakage and apoptosis. , 2000, Mutation research.

[43]  R. Kodell,et al.  Alkylation-induced sister-chromatid exchanges correlate with reduced cell survival, not mutations. , 1982, Mutation research.

[44]  P. Hanawalt,et al.  p 53-Mediated DNA Repair Responses to UV Radiation : Studies of Mouse Cells Lacking p 53 , p 21 , and / or gadd 45 Genes , 2000 .

[45]  L. Samson,et al.  Repair‐deficient 3‐methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation‐induced chromosome damage and cell killing. , 1996, The EMBO journal.

[46]  G. P. Margison,et al.  Biological Consequences of Reactions with DNA: Role of Specific Lesions , 1990 .

[47]  Bernd Kaina,et al.  c-Fos is involved in the cellular defence against the genotoxic effect of UV radiation. , 1995, Carcinogenesis.

[48]  P. Karran,et al.  DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. , 1995, Cancer research.

[49]  M. Tomicic,et al.  Expression of yeast but not human apurinic/apyrimidinic endonuclease renders Chinese hamster cells more resistant to DNA damaging agents. , 1997, Mutation research.

[50]  F. Marks,et al.  Skin tumor promotion by phorbol esters is a two-stage process. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. Gerson,et al.  The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase. , 1993, Science.

[52]  N. Fusenig,et al.  Cytogenetic effects caused by phorbol ester tumor promoters in primary mouse keratinocyte cultures: correlation with the convertogenic activity of TPA in multistage skin carcinogenesis. , 1988, Carcinogenesis.

[53]  Samuel H. Wilson,et al.  Cells deficient in DNA polymerase beta are hypersensitive to alkylating agent-induced apoptosis and chromosomal breakage. , 1999, Cancer research.

[54]  S. Morris,et al.  The relationship between sister-chromatid exchange induction and the formation of specific methylated DNA adducts in Chinese hamster ovary cells. , 1983, Mutation research.

[55]  B. Kaina,et al.  Overexpression of human DNA repair protein N-methylpurine-DNA glycosylase results in the increased removal of N-methylpurines in DNA without a concomitant increase in resistance to alkylating agents in Chinese hamster ovary cells. , 1992, Carcinogenesis.

[56]  B. Kaina,et al.  Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. , 2000, Cancer research.

[57]  B. Kaina,et al.  Apoptosis triggered by DNA damage O6-methylguanine in human lymphocytes requires DNA replication and is mediated by p53 and Fas/CD95/Apo-1 , 2004, Oncogene.

[58]  A. Loveless,et al.  Possible Relevance of O–6 Alkylation of Deoxyguanosine to the Mutagenicity and Carcinogenicity of Nitrosamines and Nitrosamides , 1969, Nature.

[59]  B. Kaina.  DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. , 2003, Biochemical pharmacology.

[60]  P. Karran,et al.  Mismatch binding proteins and tolerance to alkylating agents in human cells. , 1990, Mutation research.

[61]  N. Fusenig,et al.  Tumor induction in initiated mouse skin by phorbol esters and methyl methanesulfonate: correlation between chromosomal damage and conversion ('stage I of tumor promotion') in vivo. , 1989, Carcinogenesis.

[62]  Y. Shiloh.  ATM and ATR: networking cellular responses to DNA damage. , 2001, Current opinion in genetics & development.

[63]  F. D. de Serres,et al.  Molecular dosimetry of the chemical mutagen ethyl methanesulfonate. Quantitative comparison of the mutagenic potency in Neurospora crassa and Saccharomyces cerevisiae. , 1983, Mutation research.

[64]  B. Kaina,et al.  p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents , 1998, Oncogene.

[65]  B. Kaina,et al.  Targeted expression of human O(6)-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis. , 1996, Cancer research.

[66]  F. Palitti,et al.  Molecular mechanisms involved in the production of chromosomal aberrations. II. Utilization of Neurospora endonuclease for the study of aberration production by X-rays in G1 and G2 stages of the cell cycle. , 1980, Mutation research.

[67]  B. Kaina.  The interrelationship between SCE induction, cell survival, mutagenesis, aberration formation and DNA synthesis inhibition in V79 cells treated with N-methyl-N-nitrosourea or N-methyl-N'-nitro-N-nitrosoguanidine. , 1985, Mutation research.

[68]  D. Cooper,et al.  Alkylpurine–DNA–N-Glycosylase Knockout Mice Show Increased Susceptibility to Induction of Mutations by Methyl Methanesulfonate , 1998, Molecular and Cellular Biology.